Volume 44, Issue 2 , Pages 168-171, June 2005
Methotrexate Followed by Suctional Curettage: A Successful Treatment for Cesarean Scar Pregnancy
Summary
Objective
To report the conservative management of a patient with cesarean scar pregnancy.
Case Report
A 28-year-old woman, gravida 3, para 2, was initially diagnosed by transvaginal sonography to have a single viable gestation in a uterine scar. A single dose of systemic methotrexate 50 mg was given intramuscularly. A suctional curettage was then performed successfully. Serum levels of β-human chorionic gonadotropin returned to normal 21 days later. The patient had suffered from persistent vaginal spotting for 2 months, but no major complications were noted at follow-up.
Conclusion
To preserve fertility, systemic intramuscular methotrexate followed by suctional curettage may be a safe treatment alternative for cesarean scar pregnancies.
Key Words: cesarean scar pregnancy , methotrexate , transvaginal ultrasonography
No full text is available. To read the body of this article, please view the PDF online.
PII: S1028-4559(09)60132-7
doi:10.1016/S1028-4559(09)60132-7
© 2005 Taiwan Association of Obstetric & Gynecology. Published by Elsevier Inc. All rights reserved.
Volume 44, Issue 2 , Pages 168-171, June 2005
